Tech Company Financing Transactions

Appili Therapeutics Funding Round

Appili Therapeutics, based in Halifax NS, secured $7.3 million in funding from United States Air Force Academy.

Transaction Overview

Announced On
5/8/2023
Transaction Type
Venture Equity
Amount
$7,300,000
Round
Undisclosed
Investors
Proceeds Purpose
This fund will be used to kick-off ATI-1701 early-stage development and regulatory activities. As the initial activities progress, Appili will be engaging USAFA for additional tranches of funding to continue development through IND. ATI-1701, our biodefense vaccine candidate, is the Company's potential first-in-class vaccine candidate for the prevention of infection with Francisella tularensis, the causative agent of tularemia and a top-priority biothreat.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1344 Summer St. 21
Halifax NS, B3H 0A8
Canada
Email Address
Overview
Appili Therapeutics is developing novel approaches to lead the fight against infectious disease. Despite numerous achievements in the development of anti-infectives, infectious disease remains the leading cause of death worldwide.
Profile
Appili Therapeutics LinkedIn Company Profile
Social Media
Appili Therapeutics Company Twitter Account
Company News
Appili Therapeutics News
Facebook
Appili Therapeutics on Facebook
YouTube
Appili Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Sullivan
  Kevin Sullivan LinkedIn Profile  Kevin Sullivan Twitter Account  Kevin Sullivan News  Kevin Sullivan on Facebook
Chief Financial Officer
Kimberly Stephens
  Kimberly Stephens LinkedIn Profile  Kimberly Stephens Twitter Account  Kimberly Stephens News  Kimberly Stephens on Facebook
VP - Bus. Development
Armand Balboni
  Armand Balboni LinkedIn Profile  Armand Balboni Twitter Account  Armand Balboni News  Armand Balboni on Facebook
VP - Manufacturing
Myriam Triest
  Myriam Triest LinkedIn Profile  Myriam Triest Twitter Account  Myriam Triest News  Myriam Triest on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/8/2023: Pudu Robotics venture capital transaction
Next: 5/8/2023: Slick venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary